Medtech Capital and the New Frontier
March 17 8:10-8:50am
In his presentation, David Weild, former Vice Chairman of NASDAQ and recognized "father of the JOBS Act" will share how the democratization of capital is intersecting with healthcare innovation. He'll discuss why this is a monumental time for medtech startups, and their investors. He'll discuss how only half of the battle has been fought, however. Weild will share his view on why we need a new model IPO market to really turbocharge innovation in medical devices. Not only will he describe where we are at, but more importantly he'll inspire us to see where we can go.
Roundtable Keynote: A View from All Sides of the Medtech Innovation Table
March 16th 8:10-8:50am
A lively discussion to explore lessons learned and opportunities ahead.
Medtech M&A and Deal-Making Perspectives
March 16 12:50-1:30pm
Let's find out directly from major strategics on what deals they are hunting for and hear their outlook on M&A activity in the coming year.
Managing Director, Healthcare Investment Banking, Medical Devices, Jefferies
Looking through the Loupes: An End User’s Perspective
March 18 9:50-10:30
After the Capital Raise: Accelerating into Growth Stage
March 17 1:30-2:10pm
A lively discussion with CEOs that have successfully raised multiple rounds of capital, and now are accelerating into the next stages of growth. An unfiltered discussion about the challenges of commercialization, available resources, and how to proactively plan for growth.
What Do Strategics Want?
March 17 5:00-5:45pm
Let's get into it with senior executives from top strategics and find out what kind of deals they are looking for, right now.
Evolving Business Models in Medtech with Focus on Digital Health
Building a successful digital health business involves several strategic steps. Although many digital health products and services feature cutting-edge technology, innovative technology alone does not succeed in isolation. Monetizing the digital health assets as a standalone or being a part of medical device solutions needs innovation in business plans to engage with various stakeholders, patients, providers, and payers. The panel will focus on digital health business models and challenges to success.
New Medtech Incubator Models & Early Stage Investing
March 16 1:35-2:15pm
This panel will explore how a new model of incubators and early-stage corporate investors are driving innovation.
Intelligent/Digital Surgery: Innovation & Opportunities Evolving Rapidly
March 17 2:10-2:50pm
This panel will explore one of the hottest areas in medtech. Where are we and how far do we have to go? Hear the views of the investor, innovator, and strategic.
Same Goal, Different Paths: CEO Spotlight on Raising Capital
March 16 8:00-8:40pm
This panel will explore different methods to raise capital and explore why these successful CEOs chose their path. We'll discuss the challenges CEOs in our space experience, and address how those challenges can be overcome.
Medtech Investing: What VCs Want Right Now
March 17 7:15-7:55pm
How have recent market dynamics changed the strategies of active medtech VCs? What kind of deals are they looking and what is catching their interest at LSI USA '22?
Medtech Venture Investing
March 16 7:15-7:55pm
Let's dig deep and find out what these VCs are looking for and find out where they are focusing their next round of investments.
How Leading Medtech Scaleups Are Accelerating Time to Market
March 17 8:00-8:40pm
COO & Head of Business Development, Regulatory, Clinical & Quality Services, Veranex
Leveraging Real World Evidence Generation: From Regulatory to Market Access
March 16 5:05-5:45pm
The Three I's of Emerging Innovation Ecosystems: Infrastructure, Innovators, Investors
March 18 8:05-8:45pm
Strategy: How to Win with Today’s IDNs and GPOs
March 16 2:15-2:55pm
In 2022, how will major providers decide which products meet their needs? How do they decide who wins, and why do so many products never even get an evaluation? What other market trends, nuances, and inside guidance should innovators (and their investors) be thinking about?
Chief Supply Chain Officer, Stanford Health Care, Stanford Children’s Health, Stanford Medicine
Jimmy Chung, MD
Chief Medical Officer, Advantus Health Partners, a subsidiary of Bon Secours Mercy Health
Senior Vice President, Integrated Support Services and Technology Sourcing, Trinity Health
Family Offices & Angels Investing in Medtech: The Inside Track
March 18 2:30-3:10pm
Web3, NFTs, and Decentralized Science: The Most Important Topic That You Don't Understand (But Should)
Date and Time TBA Shortly
Upending the Medtech Sales Model
March 17 12:45-1:25
In this interactive panel moderated by CEO Scott Carson of MRP, you will hear about the future of the changing Medtech sales landscape and understand the implications it will have on our industry. Questions that will be addressed:
Investors: Can you get to market quicker?
CEOs: Why does Reddit matter?
Innovators: If you can go to market directly, what changes?
Regulatory: What about patient safety?
And much more...